Regionally Stratified Psoriasis Case Identification and Misclassification Correction in National Health Insurance Claims Data in Indonesia (PESONA): Protocol for a Serial Cross-Sectional Study (Preprint)
BACKGROUND Administrative claims from national health insurance programmes support population-level surveillance of chronic skin diseases. Case ascertainment for psoriasis is complicated by diagnostic complexity, uneven diagnostic capacity across facility tiers, and the resulting risk of diagnostic misclassification. Regional disparities in access to specialist care may further distort ascertainment. Within Indonesia’s tiered national health insurance programme, Jaminan Kesehatan Nasional (JKN), no standardised approach to psoriasis case ascertainment exists. OBJECTIVE This protocol describes the Psoriasis Epidemiology Study in Indonesia (PESONA) framework. PESONA is a replicable, step-by-step approach to psoriasis case identification, correction of diagnostic misclassification, and regional prevalence estimation in JKN administrative claims data. METHODS PESONA is a serial cross-sectional analytical protocol applied to annual JKN sample data from 2017 to 2024, provided by the Badan Penyelenggara Jaminan Sosial (BPJS) Kesehatan. It has six sequential steps across three data strata: confirmed cases from specialist encounters (Steps 1–2), derivation of misclassification parameters (Steps 3–4), and probable cases from lower-level encounters (Steps 5–6). Misclassification is quantified as the false discovery rate (FDR) and false omission rate (FOR) of referral entry diagnoses against specialist final diagnoses, by referral source. Each step is run separately in five regions defined by the Indonesia Case Base Groups (INA-CBGs) tariff regionalization. Regional prevalence is estimated per 100,000 JKN members using survey sampling weights. National case totals are obtained by summing weighted regional counts. National prevalence is estimated as a membership-weighted average of regional prevalences, and regional estimates are pooled by random-effects meta-analysis in the pooled-stratified specification, which carries between-region heterogeneity into the national confidence interval. RESULTS The study commenced in 15 January 2026. As of September 2026, analysis of the 2017–2024 sample data has been completed. CONCLUSIONS The PESONA framework offers a transparent and replicable approach to psoriasis case identification and misclassification correction in JKN claims data. Its regional stratification accounts for unequal access to specialist care. The approach may be adaptable to other chronic skin diseases and to comparable tiered health systems.
Authors
- Arief Budiyanto (ORCID: https://orcid.org/0000-0002-8924-9712)
- Darren Mark Ashcroft (ORCID: https://orcid.org/0000-0002-2958-915X)
- Shinta Trilaksmi Dewi (ORCID: https://orcid.org/0000-0001-8972-4379)
- Alison K. Wright (ORCID: https://orcid.org/0000-0002-8418-8332)
- Sensa Gudya Sauma Syahra (ORCID: https://orcid.org/0009-0001-5553-5278)
- Wega Setiabudi (ORCID: https://orcid.org/0000-0003-2510-0318)
- Sri Awalia Febriana (ORCID: https://orcid.org/0000-0002-8209-2820)
- Christopher E.M. Griffiths (ORCID: https://orcid.org/0000-0001-5371-4427)
- Ahmad Watsiq Maula (ORCID: https://orcid.org/0000-0003-1494-5403)
- Fadhilah Khairuna Larasati (ORCID: https://orcid.org/0000-0002-9019-9118)
- Sarah Khanza Nabilah (ORCID: https://orcid.org/0009-0008-2029-599X)
Publication Details
- Published
- 2026-11-17
- DOI
- https://doi.org/10.2196/preprints.117131
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- preprint